Literature DB >> 27481353

Bradyarrhythmia induced by amiodarone-sofosbuvir co-administration.

Mohammed El Amine Ghembaza1, Ali Lounici2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27481353     DOI: 10.1007/s12664-016-0684-6

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN: 0254-8860


× No keyword cloud information.
  5 in total

1.  Interaction between amiodarone and sofosbuvir-based treatment for hepatitis C virus infection: potential mechanisms and lessons to be learned.

Authors:  David J Back; David M Burger
Journal:  Gastroenterology       Date:  2015-09-28       Impact factor: 22.682

2.  Bradyarrhythmias Associated with Sofosbuvir Treatment.

Authors:  Hélène Fontaine; Arnaud Lazarus; Stanislas Pol; Caroline Pecriaux; François Bagate; Philippe Sultanik; Estelle Boueyre; Marion Corouge; Vincent Mallet; Anaïs Vallet-Pichard; Philippe Sogni; Denis Duboc
Journal:  N Engl J Med       Date:  2015-11-05       Impact factor: 91.245

Review 3.  Antiarrhythmic therapy in atrial fibrillation: indications, guidelines, and safety.

Authors:  Armin Barekatain; Mehdi Razavi
Journal:  Tex Heart Inst J       Date:  2012

4.  Extreme bradycardia after first doses of sofosbuvir and daclatasvir in patients receiving amiodarone: 2 cases including a rechallenge.

Authors:  Sophie Renet; Marie-Camille Chaumais; Teresa Antonini; Alexandre Zhao; Laure Thomas; Arnaud Savoure; Didier Samuel; Jean-Charles Duclos-Vallée; Vincent Algalarrondo
Journal:  Gastroenterology       Date:  2015-08-04       Impact factor: 22.682

Review 5.  Practical Management Guide for Clinicians Who Treat Patients with Amiodarone.

Authors:  Andrew E Epstein; Brian Olshansky; Gerald V Naccarelli; John I Kennedy; Elizabeth J Murphy; Nora Goldschlager
Journal:  Am J Med       Date:  2015-11-11       Impact factor: 4.965

  5 in total
  1 in total

1.  Assessing the impact of a combination of sofosbuvir and daclatasvir treatment for hepatitis C virus infection on heart rate, rhythm and heart rate variability using 24-hour ECG monitoring.

Authors:  Ahmed Mohamed El Missiri; Mona Mostafa Rayan; Mohamed Medhat Awad; Ahmed Ibrahim El Desoky
Journal:  Egypt Heart J       Date:  2020-07-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.